. Business Overview We are a leading biomedical innovator, addressing significant unmet needs in womens health worldwide, with a broad patent-protected portfolio of disruptive, accessible, in-office therapeutic and diagnostic products. The Company is a U.S. manufacturer that has received global regulatory approvals for its product portfolio, which is currently being commercialized in the U.S. and key international markets. FemaSeed Intratubal Insemination, a groundbreaking first-step infertility...
Q2 FY2026 — expected 2026-08-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001140361-26-012375 | EDGAR | 90K words |
| 2025-03-27 | 2024-12-31 | 0001140361-25-010598 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0001140361-24-016230 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001140361-23-014668 | EDGAR | — |
| 2022-03-24 | 2021-12-31 | 0001140361-22-011032 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001140361-25-042308 | EDGAR | 22K words |
| 2025-08-08 | 2025-06-30 | 0001140361-25-029864 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001140361-25-017985 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001140361-24-046038 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001140361-24-036299 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001140361-24-025068 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001140361-23-053090 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001140361-23-038918 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001140361-23-024144 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001140361-22-040812 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001140361-22-029076 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0001140361-22-018657 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-01 | 0001140361-26-012538 | EDGAR | 9K words |
| 2026-03-31 | 0001140361-26-012346 | EDGAR | — |
| 2026-03-20 | 0001140361-26-010591 | EDGAR | — |
| 2026-01-15 | 0001140361-26-001268 | EDGAR | — |
| 2025-12-23 | 0001140361-25-046546 | EDGAR | — |
| 2025-12-18 | 0001140361-25-045950 | EDGAR | — |
| 2025-11-14 | 0001140361-25-042304 | EDGAR | — |
| 2025-11-10 | 0001140361-25-041293 | EDGAR | — |
| 2025-11-07 | 0001140361-25-041180 | EDGAR | — |
| 2025-11-03 | 0001140361-25-040104 | EDGAR | — |
132 total filings indexed. 105 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001339005 |
| Ticker | FEMY |
| Exchange | Nasdaq |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | DE |
| Website | https://www.femasys.com |
| Listed | 2021-06-18 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report